Fumakilla Limited Share Price

Equities

4998

JP3826000006

Agricultural Chemicals

Delayed Japan Exchange 07:17:55 02/05/2024 am IST 5-day change 1st Jan Change
1,142 JPY -0.26% Intraday chart for Fumakilla Limited -3.63% +0.44%

Financials

Sales 2024 * 67B 429M 35.47B Sales 2025 * 69.4B 444M 36.74B Capitalization 18.87B 121M 9.99B
Net income 2024 * 1.5B 9.6M 794M Net income 2025 * 1.89B 12.1M 1B EV / Sales 2024 * 0.28 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.27 x
P/E ratio 2024 *
12.6 x
P/E ratio 2025 *
9.98 x
Employees 2,410
Yield 2024 *
1.92%
Yield 2025 *
2.27%
Free-Float 66.63%
More Fundamentals * Assessed data
Dynamic Chart
Fumakilla Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Fumakilla Limited(TSE:4998) dropped from S&P Global BMI Index CI
Fumakilla Limited completed the acquisition of a 80% stake in ZAPI S.p.A. CI
FUMAKILLA EUROPE S.R.L. announced that it has received €1.8 million in funding from Fumakilla Limited CI
FUMAKILLA EUROPE S.R.L. announced that it expects to receive €1.8 million in funding from Fumakilla Limited CI
Fumakilla Limited agreed to acquire 80% stake in Zapi Industrie Chimiche Spa. CI
Idemitsu Kosan Co.,Ltd. completed the acquisition of remaining 30.3% stake in SDS Biotech K.K. from group of sellers. CI
Idemitsu Kosan Co.,Ltd. entered into Share Exchange Agreement to acquire remaining 30.3% stake in SDS Biotech K.K. from group of sellers for ¥3.1 billion. CI
Certain Common Shares of Fumakilla Limited are subject to a Lock-Up Agreement Ending on 18-SEP-2018. CI
Fumakilla Limited announces an Equity Buyback for 183 shares. CI
Fumakilla Limited's Equity Buyback announced October 18, 2017 has expired. CI
Fumakilla Limited authorizes a Buyback Plan. CI
Fumakilla Ltd. completed the acquisition of remaining 26.36% stake in PT Fumakilla Nomos from Texchem Resources Bhd. CI
Fumakilla Ltd. completed the acquisition of remaining stake in Fumakilla Asia Sdn. Bhd. from Texchem Resources Bhd. CI
Umakilla Ltd. agreed to acquire remaining 30% stake in Fumakilla Asia Sdn. Bhd. from Texchem Resources Bhd for MYR 61.5 million. CI
More news
1 day-0.26%
1 week-3.63%
Current month-3.79%
1 month-1.30%
3 months-0.26%
6 months+8.87%
Current year+0.44%
More quotes
1 week
1 138.00
Extreme 1138
1 191.00
1 month
1 125.00
Extreme 1125
1 191.00
Current year
1 091.00
Extreme 1091
1 220.00
1 year
1 033.00
Extreme 1033
1 289.00
3 years
1 018.00
Extreme 1018
1 623.00
5 years
1 001.00
Extreme 1001
2 074.00
10 years
580.00
Extreme 580
2 740.00
More quotes
Managers TitleAgeSince
President 66 01/84/01
Chairman 75 01/78/01
Chief Administrative Officer 68 01/20/01
Members of the board TitleAgeSince
Chairman 75 01/78/01
President 66 01/84/01
Comptroller/Controller/Auditor 73 01/10/01
More insiders
Date Price Change Volume
02/24/02 1,142 -0.26% 15 200
01/24/01 1,145 -2.72% 40,500
30/24/30 1,177 +0.68% 33,400
26/24/26 1,169 -0.85% 22,700
25/24/25 1,179 -1.01% 19,000

Delayed Quote Japan Exchange, May 02, 2024 at 07:17 am IST

More quotes
FUMAKILLA LIMITED is a Japan-based chemical manufacturing company. The Company operates in four business divisions. The Pesticide division manufactures and sells battery-operated mosquito destroyers and insect deterrents, mat-type and liquid mosquito destroyers, fly and mosquito insecticides, fumigants, as well as cockroach repellents in Japan, South Asia and other regions. The Gardening Equipment division manufactures and sells insecticides and disinfectants for gardening use, fertilizers, immunizer, herbicides and culture soil in Japan. The Disease Prevention Agents division manufactures and sells emulsions, oil solutions, powder and rat poisons in Japan. The Household Products division manufactures and sells dehumidifying agents, clothing repellents, pollen allergy products and sanitizers in Japan.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1,145 JPY
Average target price
1,365 JPY
Spread / Average Target
+19.21%
Consensus